mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |